Evidence map›Paper›PMID 34867829›Full record

Trial reportFrontiers in endocrinology2021

Effect of Liothyronine Treatment on Dermal Temperature and Activation of Brown Adipose Tissue in Female Hypothyroid Patients: A Randomized Crossover Study.

Betty Ann Bjerkreim, Sara Salehi Hammerstad, Hanne Løvdal Gulseth, Tore Julsrud Berg, Sindre Lee-Ødegård, Anbjørg Rangberg, Christine Monceyron Jonassen, Helen Budge, David Morris, James Law and 2 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03627611 (A Randomized Crossover Study, Examining Differential Effects of Levothyroxine and Liothyronine), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03627611 phase2completednot on this map

A Randomized Crossover Study, Examining Differential Effects of Levothyroxine and Liothyronine

TypeinterventionalSponsorOslo University HospitalRan2018 to 2020Enrolled69ConditionsHypothyroidism, Biomarkers, Endocrine System DiseasesArmsLevothyroxin, Liothyronine
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Betty Ann BjerkreimDepartment of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Sara Salehi HammerstadEndocrinology, Pilestredet Park Specialist Center, Oslo, Norway.
Hanne Løvdal GulsethDepartment of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.
Tore Julsrud BergDepartment of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Sindre Lee-ØdegårdDepartment of Transplantation, Oslo University Hospital, Oslo, Norway.
Anbjørg RangbergCenter for Laboratory Medicine, Østfold Hospital Trust, Grålum, Norway.
Christine Monceyron JonassenCenter for Laboratory Medicine, Østfold Hospital Trust, Grålum, Norway.
Helen BudgeAcademic Child Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
David MorrisBioengineering Research Group, Faculty of Engineering, University of Nottingham, Nottingham, United Kingdom.
James LawAcademic Child Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Michael SymondsAcademic Child Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Erik Fink EriksenEndocrinology, Pilestredet Park Specialist Center, Oslo, Norway.
University of Nottingham · GBSpesialistSenteret Pilestredet Park · NOUniversity of Oslo · NONIHR Nottingham Digestive Diseases Biomedical Research Unit · GBNorwegian Institute of Public Health · NONorwegian University of Life Sciences · NOOslo University Hospital · NOØstfold Hospital Trust · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Thyroid hormones are essential for the full thermogenic response of brown adipose tissue (BAT) and have been implicated in dermal temperature regulation. Nevertheless, persistent cold-intolerance exists among a substantial proportion of hypothyroid patients on adequate levothyroxine (LT4) substitution. Materials and Methods: To assess if skin temperature and activation of BAT during treatment with liothyronine (LT3) differs from that of LT4 treatment, fifty-nine female hypothyroid patients with residual symptoms on LT4 or LT4/LT3 combination therapy were randomly assigned in a non-blinded crossover study to receive monotherapy with LT4 or LT3 for 12 weeks each. Change in supraclavicular (SCV) skin temperature overlying BAT, and sternal skin temperature not overlying BAT, during rest and cold stimulation were assessed by infrared thermography (IRT). In addition, abundance of exosomal miR-92a, a biomarker of BAT activation, was estimated as a secondary outcome. Results: Cold stimulated skin temperatures decreased less with LT3 Conclusion: LT3 may reduce dermal heat loss. Thermography data suggested increased BAT activation in hypothyroid patients with cold-intolerance. However, this finding was not corroborated by assessment of the microRNA biomarker of BAT activation. Clinical Trial Registration: ClinicalTrials.gov, identifier NCT03627611.

Indexed as

Adipose Tissue, BrownAdultCross-Over StudiesFemaleHumansHypothyroidismMiddle AgedNorwaySkin TemperatureThermogenesisTreatment OutcomeTriiodothyronineTriiodothyroninebrown adipose tissue (BAT)cold-induced thermogenesishypothyroidisminfrared thermographylevothyroxineliothyronine

Identifiers

PMID34867829
PMCPMC8639573
OpenAlexW3215985669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.